Traffic cops of the immune system

Molecule called IKBNS in charge of regulatory immune cell maturation

2012-11-29

(Press-News.org) This press release is available in German.

Now, scientists at the Helmholtz Centre for Infection Research (HZI) have looked into the origin of Tregs and uncovered a central role played by the protein IkBNS. Armed with this knowledge, the researchers hope to manipulate Tregs in order to either inhibit or activate the immune system. Biochemist Prof. Ingo Schmitz and his team have now published their findings in the scientific journal Immunity.

The immune system is a complex network of different types of cells and chemical messengers. The regulatory cells and other immune cells exist together in a delicate balance. Any disturbance of this balance could have serious consequences: If there are too many Tregs, the immune system might be "thwarted" and little would stand in the way of infections or tumors spreading throughout the body. By contrast, if there are too few Tregs, other immune cells could get out of control and attack the body's own tissues: autoimmune diseases like rheumatoid arthritis or the chronic inflammatory bowel disease ulcerative colitis may be a consequence. Tregs also play an important role following an organ transplant as they decide whether the body will accept or reject the donor organ.

But what it is exactly that makes immature immune cells choose the "police officer career" had eluded scientists. Schmitz and his team from the HZI, the Otto von Guericke University Magdeburg, the Charité Universitätsmedizin Berlin, the Harvard Medical School Boston, the TWINCORE in Hanover, the Eberhard Karls University Tübingen and the Heinrich Heine University Düsseldorf were now able to demonstrate that the transcription factor IkBNS contributes considerably to Treg development. The molecule promotes formation of the protein Foxp3, the Tregs' central feature. IkBNS influences the large NFkB family of transcription factors. These signaling molecules trigger a number of different inflammatory responses elicited by the immune system. "It was therefore all the more surprising for us when we identified IkBNS' central role in Treg maturation. Essentially, these are cells capable of constraining inflammation – even though IkBNS in no way influences the function of regulatory T cells," explains Dr. Marc Schuster, one of Schmitz' colleagues at HZI and the article's first author. The researchers tested their hypothesis regarding IkBNS' central role in Treg development in mice that are missing this factor. Since cells that lack IkBNS do not "become cops," the immune system's effector cells are undamped and could trigger chronic inflammation of the intestine.

The results have confirmed that further research on IkBNS is of interest from a medical perspective as well. On the one hand, it allows predicting diseases: If IkBNS is fraught with errors, this could trigger autoimmune disorders. On the other hand, one potential therapeutic goal might be "to manipulate IkBNS in such a way that we can control the number of Tregs," explains Schmitz, who, in addition to his HZI research, also has a chair at the Otto von Guericke University Magdeburg. "IkBNS stabilization could benefit autoimmune disease therapy. As far as infections or tumors are concerned, we would need to inhibit IkBNS to decrease the number of regulatory T cells. Of course, all that is still in the very distant future." But because IkBNS also plays an important role in effector cell activation, an intervention might have unforeseen consequences. "This is a challenge you face with many different therapeutic targets," adds Schmitz.

### Original publication: Marc Schuster, Rainer Glauben, Carlos Plaza-Sirvent, Lisa Schreiber, Michaela Annemann, Stefan Floess, Anja A. Kühl, Linda K. Clayton, Tim Sparwasser, Klaus Schulze-Osthoff, Klaus Pfeffer, Jochen Huehn, Britta Siegmund, Ingo Schmitz The atypical NFkB inhibitor IkBNS mediates regulatory T cell development by regulating Foxp3 induction Immunity, 2012

The research group "Systems-oriented Immunology and Inflammation Research" explores the molecular processes that make immune cells tolerant to the body's own tissues. This includes especially the cellular suicide program apoptosis.

The Helmholtz Centre for Infection Research (HZI): At the Helmholtz Centre for Infection Research in Braunschweig, scientists are studying microbial virulence factors, host-pathogen interactions and immunity. The goal is to develop strategies for the diagnosis, prevention and therapy of human infectious diseases.
http://www.helmholtz-hzi.de/en The Otto von Guericke University Magdeburg: One of the Otto von Guericke University Magdeburg Medical Faculty's research emphases is "Immunology including molecular medicine relating to inflammation". The goal is to develop new therapeutic approaches and deliver them to the patient.
www.uni-magdeburg.de END

ELSE PRESS RELEASES FROM THIS DATE:

UW-Madison scientists create roadmap to metabolic reprogramming for aging

2012-11-29

MADISON – In efforts to understand what influences life span, cancer and aging, scientists are building roadmaps to navigate and learn about cells at the molecular level. To survey previously uncharted territory, a team of researchers at UW-Madison created an "atlas" that maps more than 1,500 unique landmarks within mitochondria that could provide clues to the metabolic connections between caloric restriction and aging. The map, as well as the techniques used to create it, could lead to a better understanding of how cell metabolism is re-wired in some cancers, age-related ...

Study helps resolve debate about how tumors spread

2012-11-29

A team of scientists, led by researchers at the University of California, San Diego School of Medicine, has shown for the first time how cancer cells control the ON/OFF switch of a program used by developing embryos to effectively metastasize in vivo, breaking free and spreading to other parts of the body, where they can proliferate and grow into secondary tumors. The findings are published in the December 11 issue of the journal Cancer Cell. In 90 percent of cancer deaths, it is the spreading of cancer, known as metastasis, which ultimately kills the patient by impacting ...

Study sheds light on how pancreatic cancer begins

2012-11-29

A diagnosis of pancreatic cancer is particularly devastating since the prognosis for recovery is usually poor, with the cancer most often not detected until late stages. Research led by scientists at the University of California, San Diego and UC San Francisco Schools of Medicine examined the tumor-initiating events leading to pancreatic cancer (also called pancreatic ductal adenocarcinoma or PDA) in mice. Their work, published on line November 29 in the journal Cancer Cell, may help in the search for earlier detection methods and treatments. "Previously, it was believed ...

Short-term exposure to essential oils lowers blood pressure and heart rate

2012-11-29

The scents which permeate our health spas from aromatic essential oils may provide more benefits than just a sense of rest and well-being. For according to a new study(1) in the European Journal of Preventive Cardiology, the essential oils which form the basis of aromatherapy for stress relief are also reported to have a beneficial effect on heart rate and blood pressure following short-term exposure - and may therefore reduce the risk of cardiovascular disease. However, on the downside, those beneficial effects were reversed when exposure to essential oils lasted more ...

Prenatal exposure to testosterone leads to verbal aggressive behavior

2012-11-29

Washington, DC (November 27, 2012) –A new study in the Journal of Communication links verbal aggression to prenatal testosterone exposure. The lead researcher, at University at Buffalo – The State University of New York, used the 2D:4D measure to predict verbal aggression. This study is the first to use this method to examine prenatal testosterone exposure as a determinant of a communication trait. Allison Z. Shaw, University at Buffalo – The State University of New York, Michael R. Kotowski, University of Tennessee, and Franklin J. Boster and Timothy R. Levine, Michigan ...

Enzyme inhibition protects against Huntington's disease damage in 2 animal models

2012-11-29

Treatment with a novel agent that inhibits the activity of SIRT2, an enzyme that regulates many important cellular functions, reduced neurological damage, slowed the loss of motor function and extended survival in two animal models of Huntington's disease. The study led by Massachusetts General Hospital (MGH) researchers will appear in the Dec. 27 issue of Cell Reports and is receiving advance online release. "I believe that the drug efficacy demonstrated in two distinct genetic HD mouse models is quite unique and highly encouraging," says Aleksey Kazantsev, PhD, of ...

Biology behind brain development disorder

2012-11-29

Researchers have defined the gene responsible for a rare developmental disorder in children. The team showed that rare variation in a gene involved in brain development causes the disorder. This is the first time that this gene, UBE3B, has been linked to a disease. By using a combination of research in mice and sequencing the DNA of four patients with the disorder, the team showed that disruption of this gene causes symptoms including brain abnormalities and reduced growth, highlighting the power of mouse models for understanding the biology behind rare diseases. "Ubiquitination, ...

When good service means bad behavior

2012-11-29

Economists and professionals praise the merits of competition, as it leads to lower prices and improvements in quality. But in the automobile smog-testing industry, competition can lead to corruption and even public health problems, according to research by USC Marshall School of Business Assistant Professor of Management Victor Bennett. Bennett, along with colleagues Lamar Pierce of Washington University's Olin School of Business, Jason Snyder at the UCLA Anderson School of Management and Michael W. Toffel of Harvard Business School, found that the structure of the smog-testing ...

Study reinforces safety of whooping cough vaccine for older adults

2012-11-29

PASADENA, Calif., Nov. 29, 2012 – Immunizing older adults with the tetanus-diphtheria-acellular-pertussis vaccine (Tdap) to prevent pertussis (more commonly referred to as whooping cough) was found to be as safe as immunizing them with the tetanus and diphtheria (Td) vaccine, according to a study by Kaiser Permanente published in the journal Clinical Infectious Diseases. Researchers examined the electronic health records of nearly 120,000 people ages 65 and older at seven U.S. health systems between Jan. 1, 2006 and Dec. 31, 2010. The study looked at a number of medical ...

A new anti-windup design paradigm for control systems with actuator saturation was developed

2012-11-29

Actuator saturation is ubiquitous in engineering systems. Anti-windup approach to dealing with actuator saturation has been receiving considerable attention from both the industry and the academic community during the past decades. Professor Zongli Lin and his student Xiongjun Wu developed a new anti-windup design paradigm that is capable of achieving significantly improved performances of the resulting closed-loop system. Their work, entitled "Design of multiple anti-windup loops for multiple activations," was published in SCIENCE CHINA Information Sciences, 55(9), 2012. ...

Wiley advances Knowitall Solutions with new trendfinder application for user-friendly chemometric analysis and additional enhancements to analytical workflows

Traffic cops of the immune system

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: